Unknown

Dataset Information

0

Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.


ABSTRACT: Trelagliptin (SYR-472), a novel dipeptidyl peptidase-4 inhibitor, shows sustained efficacy by once-weekly dosing in type 2 diabetes patients. In this study, we characterized in vitro properties of trelagliptin, which exhibited approximately 4- and 12-fold more potent inhibition against human dipeptidyl peptidase-4 than alogliptin and sitagliptin, respectively, and >10,000-fold selectivity over related proteases including dipeptidyl peptidase-8 and dipeptidyl peptidase-9. Kinetic analysis revealed reversible, competitive and slow-binding inhibition of dipeptidyl peptidase-4 by trelagliptin (t1/2 for dissociation ? 30 minutes). X-ray diffraction data indicated a non-covalent interaction between dipeptidyl peptidase and trelagliptin. Taken together, potent dipeptidyl peptidase inhibition may partially contribute to sustained efficacy of trelagliptin.

SUBMITTER: Grimshaw CE 

PROVIDER: S-EPMC4915685 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.

Grimshaw Charles E CE   Jennings Andy A   Kamran Ruhi R   Ueno Hikaru H   Nishigaki Nobuhiro N   Kosaka Takuo T   Tani Akiyoshi A   Sano Hiroki H   Kinugawa Yoshinobu Y   Koumura Emiko E   Shi Lihong L   Takeuchi Koji K  

PloS one 20160621 6


Trelagliptin (SYR-472), a novel dipeptidyl peptidase-4 inhibitor, shows sustained efficacy by once-weekly dosing in type 2 diabetes patients. In this study, we characterized in vitro properties of trelagliptin, which exhibited approximately 4- and 12-fold more potent inhibition against human dipeptidyl peptidase-4 than alogliptin and sitagliptin, respectively, and >10,000-fold selectivity over related proteases including dipeptidyl peptidase-8 and dipeptidyl peptidase-9. Kinetic analysis reveale  ...[more]

Similar Datasets

| S-EPMC5835476 | biostudies-literature
| S-EPMC6612345 | biostudies-literature
| S-EPMC10838880 | biostudies-literature
| S-EPMC5347923 | biostudies-literature
| S-EPMC5217871 | biostudies-literature
| S-EPMC6955405 | biostudies-literature
| S-EPMC10499707 | biostudies-literature
| S-EPMC6151561 | biostudies-literature
| S-EPMC7920438 | biostudies-literature
| S-EPMC3898344 | biostudies-literature